Drawing for CLEARID

USPTO serial 86692989

CLEARID

Reviewed by CopyMark Law Group

Reg. 5066881Status 710
Filing date
Status date
Registration date
Oct 25, 2016
Examiner
ROSSMAN, MARY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CLEARID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael E. Pfau

MICHAEL E. PFAU REICKER PFAU PYLE & MCROY LLP1421 STATE ST STE BSANTA BARBARA, CA 93101-2507UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Diagnostic test kits for research and medical use in connection with the detection and characterization of gene expression and mutations associated with cancer through the genomic analysis of rare blood cells, namely, specimen collection tubes, blood sample stabilizing reagents, containers for collecting patient blood and plasma specimens, test forms, packaging and mailing materials, and user information insertsSECTION 8 - CANCELLEDDec 3, 2013
044Providing medical testing and analysis services and information in the field of cancer research and disease classification through the genomic analysis of rare blood cells, namely, providing clinical and medical laboratory tests that detect gene expression and mutations associated with cancer, the evaluation of such tests, and information in the fields of cancer screening, diagnosis and treatment, all for diagnostic or treatment purposesSECTION 8 - CANCELLEDDec 3, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2023C8..CANCELLED SEC. 8 (6-YR)—
Oct 25, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 17, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 25, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 9, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 9, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 20, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 1, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 30, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 29, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 29, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 15, 2016ALIEASSIGNED TO LIE—
Jun 8, 2016NREVNOTICE OF REVIVAL - E-MAILED—
Jun 7, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2016PETGPETITION TO REVIVE-GRANTED—
Jun 7, 2016PROATEAS PETITION TO REVIVE RECEIVED—
Jun 1, 2016MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 31, 2016ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 2, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 2, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 2, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 22, 2015DOCKASSIGNED TO EXAMINER—
Jul 21, 2015MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 20, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 17, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance